FDA warns on safe­ty threat posed by 2 drugs ini­tial­ly backed by Trump for Covid-19 — fol­low­ing an emer­gency use au­tho­riza­tion

Two of Pres­i­dent Trump’s ini­tial top picks as near-term ther­a­peu­tic reme­dies for Covid-19 are the sub­ject of an FDA safe­ty warn­ing to­day.

The agency is­sued an alert on Fri­day on hy­drox­y­chloro­quine and chloro­quine for “se­ri­ous and po­ten­tial­ly life-threat­en­ing heart rhythm prob­lems, that have been re­port­ed with their use for the treat­ment or pre­ven­tion of COVID-19.”

Trump, whose most re­cent mus­ings on Covid-19 fo­cused on the use of dis­in­fec­tants (dan­ger­ous) and light (?) to stop the virus, ear­li­er made re­peat­ed sup­port­ive com­ments re­gard­ing chloro­quine and hy­drox­y­chloro­quine, which he has cit­ed as a pow­er­ful drug that could be a po­ten­tial “game chang­er” and which couldn’t hurt any­one who tried it.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.